ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
41 announcements
Zota Health Care invested ₹20.20 Crore in its subsidiary, Davaindia Health Mart, via a rights issue. This capital supports strategic store expansion and working capital needs.
Zota Health Care recommended a 10% final dividend (Re. 1 per share) for FY2025-26. The payout remains subject to shareholder approval at the upcoming AGM.
Zota Health Care confirmed zero deviation in utilizing ₹722.50 Crore raised via preferential issues and QIP. Funds were fully deployed toward stated corporate and expansion objects.
Zota Healthcare Ltd reported revenue from operations of ₹163.2 Cr (+67.7% YoY) and a net loss of ₹14.5 Cr for Q4 FY26.
Zota Health Care reported FY26 consolidated revenue of ₹538.66 Crore and recommended a 10% dividend. The board also approved a ₹20.20 Crore investment in its subsidiary.
Zota Health Care appointed actor Akshay Kumar as brand ambassador for its UGO Generic brand. The partnership aims to expand affordable healthcare access across India.
Zota Health Care Limited confirmed full utilization of its ₹179.07 Crore preferential issue proceeds. CRISIL Ratings' report indicates zero unutilized funds as of March 31, 2026.
Zota Health Care Limited shareholders approved a special resolution via postal ballot to authorize the board to provide loans, guarantees, or securities up to ₹1,000 Crore. The resolution, passed with 97.96% majority, enables the company to exceed limits specified under Section 186 of the Companies Act, 2013 for strategic financial flexibility.
Zota Health Care Limited clarified its proposal to increase borrowing and investment limits from ₹500 Crore to ₹1,000 Crore following a proxy advisory report. The company intends to maintain headroom for strategic acquisitions and working capital support for its subsidiary, Davaindia Health Mart Limited, to manage its extensive store network.
Zota Health Care Limited submitted a clarification to NSE regarding its September 2025 financial results. The company corrected a clerical error in the comparative balance sheet data and provided a machine-readable PDF format. Management confirmed there are no changes to the previously reported financial figures.
Zota Health Care Limited announced the addition of 248 Davaindia stores during Q4FY26, bringing its total operative store count to 2,579 as of March 31, 2026. The expansion was driven primarily by 218 new COCO stores managed by its subsidiary. This robust growth reflects the company's continued retail footprint expansion.